The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Qianqian Yang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Cell Biology & Department of Thoracic Surgery Ren Ji Hospital, Shanghai Jiao Tong University School of Medic…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Histones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Polycomb repressive complex 2 (PRC2) is responsible for depositing H3K27me3 and plays essential roles in gene silencing during development and cancer. Meanwhile, the nuclear exosome targeting (NEXT) complex facilitates the degradation of numerous noncoding RNAs in the nucleoplasm. Here we find that the functional deficiency of the NEXT complex leads to an overall decrease in H3K27me3 levels. Specifically, ZCCHC8 depletion results in significant upregulation of nascent long noncoding RNAs (lncRNAs) containing G-quadruplex (G4) and U-Rich motifs (G4/U-Rich lncRNAs). The G4 motif binds to EZH2, blocking the chromatin recruitment of PRC2, while the U-Rich motif is specifically recognized by the NEXT complex for RNA exosome-mediated degradation. In tumor tissues with high ZCCHC8 expression in clear cell renal cell carcinoma (ccRCC) and lung adenocarcinoma (LUAD) patients, the NEXT complex excessively degrades nascent G4/U-Rich lncRNAs. Consequently, PRC2 core subunits are released and recruited to neighboring genomic loci, resulting in increased H3K27me3 levels and downregulation of adjacent genes, including tumor suppressors like SEMA5A and ARID1A. Notably, the EZH2 inhibitor Tazemetostat (EPZ-6438) exhibits greater sensitivity in cells with higher ZCCHC8 expression. Altogether, our findings demonstrate a novel mechanism that the NEXT complex regulates H3K27me3 levels by degrading nascent G4/U-Rich lncRNAs in cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Cell Biology & Department of Thoracic Surgery Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai 200025, China.
- Department of Urology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
ORCID-Profile: Jianxiu Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Q., Zhou, Z., Li, L., Lu, R., Hou, G., Huang, C., Huang, J., Li, H., Zhang, Y., Li, J., Zhang, Y., Xu, A., Chen, R., Wang, Y., Zhao, X., Huang, J., Wang, Y., Zhao, X., & Yu, J. (2025). The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf107
Vancouver
Yang Q, Zhou Z, Li L, Lu R, Hou G, Huang C, et al. The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf107
BibTeX
@article{Yang2025,
author = {Yang, Qianqian and Zhou, Zihan and Li, Lian and Lu, Runhui and Hou, Guofang and Huang, Caihu and Huang, Jiayi and Li, Hongyan and Zhang, Yafan and Li, Junya and Zhang, Yixin and Xu, Anan and Chen, Ran and Wang, Yanli and Zhao, Xian and Huang, Jian and Wang, Yiwei and Zhao, Xiaojing and Yu, Jianxiu},
title = {The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf107}
}
EUVIMED